Sepsis Diagnostic Market : Global Market Estimation, Dynamics, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Sepsis Diagnostic Market: By Technology (Microbiology, Molecular Diagnostics, Immunoassays, Flow Cytometry), By Pathogen Type (Bacterial Sepsis [Gram-Positive Bacteria and Gram-Negative Bacteria], Fungal Sepsis, and Others), By Method (Conventional Diagnostics and Automated Diagnostics), By Test Type (Laboratory Tests and Point-Of-Care Tests), By End User (Hospitals, Pathology & Reference Laboratories)   and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

Sepsis Diagnostic Market size was valued at USD 585.82 million in 2021, growing at a CAGR of 7.62% from 2022-28. Due to increase in prevalence of sepsis which may lead to organ dysfunction and acute alteration in mental status and even it may cause death in severe cases. Moreover, the different procedures of treatment that can cause sepsis are also increasing, and rise in R&D activities for the development of sepsis diagnostics are the major factors that are driving the growth of the global market over the forecast timeframe. This report studies global market dynamics elaborately to indentify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global sepsis diagnostic market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the global sepsis diagnostic market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in global sepsis diagnostic products.

Sepsis Diagnostic Market

MARKET SUMMARY
-
7.62%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 7.62%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Sepsis Diagnostic Market

  • The global sepsis diagnostic market report gives comprehensive outlook on sepsis diagnostic technology across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.
  • The report on global market gives historical, current, and future market sizes (US$ Mn) on the basis of Technology, Pathogen Type, Method, Test Type, End User, and region.
Market Key Players
  • Roche Diagnostics (Switzerland)
  • Becton, Dickinson and Company (U.S.)
  • Abbott (US)
  • bioMérieux (France)
  • Danaher (US)
  • Luminex (US)
Drivers And Restraints

Sepsis Diagnostic Market

Increase in the prevalence of sepsis is a key factor drive the global sepsis diagnostic market. According to World Health Organization 2018, approximately 6 Mn death occurred due to sepsis around the globe. Moreover, the raise in funding for the R&D activities by public and private sectors, growing healthcare awareness and health care spending and the occurrence of Hospital Acquired Infection are anticipated to propel the global sepsis diagnostic market over the forecast years.


North-America got significant share

Sepsis Diagnostic Market

North America accounted for larger revenue share in global sepsis diagnostic market with significant CAGR. Major cause of deaths in US are due to sepsis poisoning therefore, the demand for diagnostic products is high over there. Increase in prevalence of sepsis, advanced healthcare systems, and rise in R&D activities for the development of sepsis diagnostics, are anticipated to drive the market. Europe sepsis diagnostic market projected to grow at significant rate owing to increase in research and development on new procedures in the market for infectious disease treatment, favorable reimbursement policies, and increase in healthcare expenditure are expected to enhance the market.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market and forecast
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

 

Segmentation

Sepsis Diagnostic Market


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Company Profile

  • Roche Diagnostics (Switzerland)
  • Becton, Dickinson and Company (U.S.)
  • Abbott (US)
  • bioMérieux (France)
  • Danaher (US) Luminex (US)
  •  Immunexpress (US)
  • Cepheid Inc (United States)
  • Bruker (U.S)
  • Quidel Corporation (U.S.)

Description

Sepsis Diagnostic Market size was valued at USD 585.82 million in 2021, growing at a CAGR of 7.62% from 2022-28. Due to increase in prevalence of sepsis which may lead to organ dysfunction and acute alteration in mental status and even it may cause death in severe cases. Moreover, the different procedures of treatment that can cause sepsis are also increasing, and rise in R&D activities for the development of sepsis diagnostics are the major factors that are driving the growth of the global market over the forecast timeframe. This report studies global market dynamics elaborately to indentify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global sepsis diagnostic market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the global sepsis diagnostic market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in global sepsis diagnostic products.

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX